Graphical Abstract Highlights d Kupffer cells (KCs) capture circulating S. aureus in the liver d Macrophage receptor CRIg, but not complement, is required for pathogen capture by KCs d CRIg directly binds Gram-positive bacteria via lipoteichoic acid (LTA) recognition d CRIg-LTA recognition is required for clearance of circulating Gram-positive bacteria
In Brief
Liver macrophages called Kupffer cells (KCs) capture circulating pathogens. Using intravital imaging to visualize bacterial capture by KCs, Zeng et al. discover that CRIg functions as a pattern recognition receptor on KCs to directly bind Gram-positive bacteria via lipoteichoic acid (LTA). CRIg-LTA recognition is required for clearance of circulating bacteria.
INTRODUCTION
The liver has been well known as a blood-filtering organ. The unique portal venous blood inflow exposes the liver to a tremendous variety of food antigens, metabolic intermediates, and microbiota-derived products, all of which must be cleared by the liver to maintain tissue homeostasis (Crispe, 2009) . Another key function of the liver is the clearance of blood-borne pathogens during infections to prevent bacterial dissemination and infection of more susceptible organs (e.g., brain, kidney) leading to sepsis and death . This bacterial filtration function would also make the liver an essential firewall eradicating gut-resident commensal bacteria that have translo-cated into blood (Balmer et al., 2014) . Hence, understanding how the liver traps and clears circulating bacteria would be of broad therapeutic interest for the treatment of systemic bacteremia.
Kupffer cells are the largest population of tissue resident macrophages and are the key players for bacterial capture in the liver. These cells reside in liver sinusoids, forming an extensive scavenger network that actively and constitutively probes the slowflowing sinusoidal blood, trapping and phagocytosing circulating bacteria (Hickey and Kubes, 2009 ). Sequestration of bacteria by Kupffer cells is necessary for an orchestrated intravascular immune response, including the rapid docking of platelets, recruitment of circulating neutrophils, attraction of patrolling invariant natural killer T cells, and activation of adaptive immune cells, which eventually all contribute to eliminating the infections (Wong et al., 2013; Lee et al., 2010; Egen et al., 2008) . A key prerequisite to initiate this intravascular immunity is the efficient capture of bacteria from the bloodstream by Kupffer cells; however, the underlying mechanisms have not been fully elucidated. Despite the fact that numerous studies point to a role for opsonins, including antibodies and complement, which facilitate the uptake of bacteria by phagocytes under static conditions (Aderem and Underhill, 1999; Flannagan et al., 2012) , bacterial interaction with host cells under flow conditions is largely affected by the shear forces (Isberg and Barnes, 2002) . Therefore, whether these opsonins are involved in Kupffer-cell-mediated bacterial capture in vivo under flow conditions remains unclear.
Complement Receptor of Immunoglobulin superfamily (CRIg) has been identified as a receptor that recognizes the activated form of complement component C3, specifically C3b and iC3b, which opsonize pathogens, apoptotic cells, or foreign antigens (Holers, 2014) . CRIg was found to be expressed on a restricted population of tissue-resident macrophages under steady state, notably on Kupffer cells Vogt et al., 2006) . Mice genetically deficient in CRIg showed dramatically reduced capture of Staphylococcus aureus (S. aureus) and Listeria monocytogenes (L. monocytogenes) by Kupffer cells and exhibited much greater susceptibility to bacterial infection . However, it should be noted that many pathogens have evolved ways of subverting or evading the complement system. This would theoretically leave the host completely susceptible to dissemination. In fact, it has been reported that depletion of complement has no impact on Kupffercell-mediated phagocytosis of L. monocytogenes (Gregory et al., 2002) . These data raise the critical question whether complement is absolutely necessary for CRIg-mediated bacterial capture by Kupffer cells.
A major difficulty in studying bacterial capture by the liver is that in vitro isolation of Kupffer cells leads to rapid loss of cellular function, underscoring the need for in vivo visualization of bacterial capture. Therefore, in this study, spinning-disk confocal intravital microscopy was applied to directly visualize the very dynamic process of bacterial capture within liver sinusoids. This approach enabled identification of the key immune components needed for catching of blood-borne bacteria under flow conditions in vivo. We found that Kupffer-cell-mediated S. aureus capture largely relied on CRIg but was independent of opsonins, including complement or antibodies. Instead, CRIg directly bound the Gram-positive cell wall component lipoteichoic acid (LTA), and this interaction was involved in hepatic sequestration of circulating bacteria. Our study thus highlights a mechanism for bacterial catching in the liver that helps prevent systemic bacterial dissemination, which may have implications for treatment of Gram-positive bacteremia.
RESULTS
Capture of Circulating S. aureus Is Dependent on Kupffer Cells and CRIg, but Not Complement S. aureus represents a leading cause of both community-acquired and nosocomial bacteremia. Using an intravenous S. aureus (USA-300, derived from a community-acquired methicillin-resistant strain) infection model, we found that the majority (60%-80%) of administrated bacteria were quickly trapped within the liver ( Figure 1A ), confirming the fundamental role of the liver in clearing blood-borne infections. To understand how the liver captured bacteria from the bloodstream, we took advantage of liver intravital imaging to directly visualize the dynamic interactions between circulating bacteria and liver cells. Time-lapse images showed that GFP-expressing S. aureus were caught immediately after they entered into liver sinusoids (Movie S1). Once caught, most of these bacteria colocalized with F4/80-labeled Kupffer cells but not with neutrophils, endothelium, or hepatocytes. Neutrophils were recruited into liver as early as 20 min post-infection, but essentially all bacteria were already sequestered in Kupffer cells ( Figure 1B ). 3D reconstitution with increasing transparency of Kupffer cells indicated that the trapped S. aureus were inside Kupffer cells ( Figure 1C ) (i.e., could not be seen in Figure 1Ci until the Kupffer cells were made more translucent [Figures 1Cii and 1Ciii] ). Depletion of Kupffer cells with clodronate liposomes completely abrogated the capture of bacteria in the liver, whereas control liposomes had no effect ( Figure 1D ). Instead, one could see fluorescent bacteria freely streaking through the sinusoids (Movie S1) in Kupffer-cell-depleted mice. These data clearly demonstrate that Kupffer cells are the major cells that catch circulating bacteria in the liver via a mechanism not found on other immune cells such as neutrophils.
We next explored how Kupffer cells captured bacteria under shear conditions. While the dominant complement receptor for phagocytosis under static conditions on macrophage is CR3 (Mac-1) (Aderem and Underhill, 1999) , CR3 À/À Kupffer cells were able to catch bacteria equally well as wild-type (WT) Kupffer cells under shear conditions ( Figure 1E ). Previous work reported that a specific complement receptor-CRIg-on Kupffer cells was very effective at catching S. aureus and L. monocytogenes by Kupffer cells. We confirmed that CRIg co-stained with F4/80 in the liver of WT mice, and CRIg À/À mice completely lacked CRIg expression ( Figure 1F ). Furthermore, CRIg-deficient mice showed a 70% reduction in hepatic capture of circulating S. aureus ( Figures 1E and 1F ; Movie S2) despite having a comparable amount of F4/80 + Kupffer cells as WT mice ( Figure S1 ). As a result, in the absence of CRIg, there was rapid systemic bacterial dissemination, with fewer S. aureus in liver, but 5-fold more bacteria in lung and spleen and around 100-fold more bacteria in blood ( Figure 1G ).
Opsonins, including complement and antibodies, greatly enhance macrophage-mediated phagocytosis under static conditions. CRIg was originally identified as a receptor for C3b and iC3b Wiesmann et al., 2006) . However, mice deficient in complement components C3, C4, or C5 were as efficient as WT mice in capturing S. aureus by the liver (Figure 1H ; Movie S2). The catching ability also remained intact in antibody-deficient Rag1 À/À mice ( Figure 1I ; Movie S2). These data indicated that complement and antibodies played dispensable roles in catching of circulating S. aureus by Kupffer cells under shear conditions. To confirm this, we further tested the catching of S. aureus in complement and Fc receptor double knockout mice (C3 À/À /FcgR À/À , which are deficient for C3 and common g chain of Fc receptors). These animals also retained the ability to capture S. aureus as efficiently as WT mice, further ruling out a role for complement and IgG ( Figure 1J ). Taken together, these data indicate that capture of circulating S. aureus by Kupffer cells is dependent on CRIg but independent of opsonins. This paradox prompted us to hypothesize that there is an alternative ligand interacting with CRIg to promote bacterial capture in the liver.
CRIg Directly Binds Gram-Positive Bacteria
The findings that opsonins (e.g., complement and antibody) were dispensable, but CRIg was indispensable, for the capture of circulating S. aureus implies that Kupffer cells may be able to catch unopsonized S. aureus via CRIg. To test this hypothesis, we determined if CRIg could directly bind to unopsonized S. aureus. Indeed, the recombinant extracellular domain of mouse or human CRIg, labeled with Alexa fluor-647(AF-647), bound unopsonized S. aureus (Figure 2A ). To ensure that this binding was CRIg mediated and was not due to free dye leaching into cells, we used equal amounts of AF-647-labeled a-toxin as a control, which would not bind the pathogen but would also release some free dye (Figure 2A ). Increasing concentrations of CRIg enhanced binding to S.aureus. By contrast, CRIg was not able to directly bind unopsonized Escherichia coli (E. coli, Xen14) ( Figure 2B ). Immunofluorescence confirmed binding of S.aureus but not E.coli with AF-647-labeled CRIg ( Figure 2C ). Because S. aureus and E. coli are prototypical Gram-positive and Gram-negative bacteria, respectively, we tested several other Gram-positive and Gram-negative bacterial strains; CRIg bound directly to all of the Gram-positive strains tested, including S. aureus (MW2), L. monocytogenes, and Bacillus cereus (B. cereus). In contrast, CRIg did not bind directly to any of the Gram-negative strains that were tested, including E. coli (TOP10), Salmonella typhimurium, and Pseudomonas aeruginosa ( Figure 2D ). Taken together, these observations reveal an unexpected direct interaction between CRIg and Gram-positive bacteria.
CRIg Does Not Recognize Bacterial Surface Proteins or Peptidoglycan
The finding that CRIg selectively bound Gram-positive but not Gram-negative bacteria raised the possibility that a surface protein or a cell wall component of the Gram-positive bacteria was recognized by CRIg. Gram-positive bacteria display many proteins on their surface to facilitate the interaction with host cells, which prompted us to examine whether CRIg recognized surface proteins on Gram-positive bacteria. Sortase A has been (E) Age-matched WT, CR3 À/À , and CRIg À/À mice were infected with GFP-S. aureus; the numbers of captured bacteria per FOV within liver was counted 20 min post-infection. (F) High-magnification intravital liver images showing bacterial capture in WT or CRIg À/À mice. AF 555-labeled anti-CRIg (red); efluor-660 anti-F4/80-labeled Kupffer cells (blue), and S. aureus-GFP (bright green) were shown. Yellow arrows indicate the captured S. aureus. Scale bar: 30 mm. (G) WT or CRIg À/À mice were i.v. infected with 5 3 10 7 CFU S. aureus; bacterial load in liver, blood, kidney, and spleen were determined at 20 min post-infection. (H-J) (H) Age-matched C3 À/À , C4 À/À , and C5 À/À mice; (I) WT and Rag1 À/À mice; and (J) WT and C3 À/À FcgR À/À mice were i.v. infected with 5 3 10 7 CFU S. aureus; liver intravital images were performed. The numbers of captured bacteria per FOV were counted 20 min post-infection. Data were expressed as mean ± SEM, each dot represents one mouse; a total of six to seven FOV were counted per mouse for intravital studies. Representative results of at least two experiments were shown. *p < 0.05, **p < 0.01, and ***p < 0.001; N.S., no significance. See also Figure S1 and Movies S1 and S2.
identified as the critical transpeptidase supporting the anchor of secreted proteins to the peptidoglycan layer of S. aureus and many other Gram-positive bacteria (Mazmanian et al., 1999) . In a Sortase A mutant S. aureus strain (DsrtA), the bacteria lost the ability to display surface proteins; however, CRIg bound this Sortase A mutant as efficiently as WT S. aureus ( Figure 3A) . In vivo, Kupffer cells captured similar amounts of S. aureus DsrtA as WT S. aureus ( Figure 3B ). These data indicated that surface proteins displayed on Gram-positive bacteria were not likely the ligands for CRIg.
The Gram-positive cell wall is unique in having a thick, surfaceexposed peptidoglycan layer along with incorporated teichoic acids. We chose to look if these evolutionarily conserved molecular patterns could bind CRIg. Purified peptidoglycan did not inhibit the binding of CRIg to S. aureus, as CRIg was able to efficiently bind S. aureus even in the presence of high concentrations of peptidoglycan ( Figure 3C ). In addition, no binding between FITC-labeled peptidoglycan and CRIg-expressing Jurkat T cells was detected ( Figure 3D) . These data ruled out the possibility of peptidoglycan as a ligand for CRIg.
CRIg Recognizes Lipoteichoic Acid
Teichoic acids are vastly present in the Gram-positive cell wall and are either connected to peptidoglycan (wall teichoic acids [WTAs]) or to the cytoplasmic membrane (LTAs). Both are produced by S. aureus and most other Gram-positive bacteria. The addition of purified LTA dose-dependently reduced the binding of CRIg to S. aureus. In fact, purified LTA at 10-40 mg/ml completely blocked the binding of both mouse and human CRIg to S.aureus ( Figure 3E ; data not shown). Addi- tionally, preincubation of S. aureus with anti-LTA antibody could partially inhibit bacterial binding to CRIg (Figures 3F  and 3G ). The interaction between CRIg and LTA was further demonstrated by ELISA. Despite the unavoidable high background binding, we noted significantly higher binding of LTA to CRIgcoated plates than to control BSA-coated plates ( Figure 3H ). Moreover, soluble CRIg could antagonize the binding of LTA to CRIg-coated plates, demonstrating a specific binding between CRIg and LTA ( Figure 3I ). To excluded the possibility that WTA, a known contaminant of LTA preparations, was not the ligand (Brown et al., 2013) , a WTA-deficient S. aureus mutant (DtagO) was tested and found to be competent in binding to CRIg ( Figure 3J ). Taken together, these data identified LTA as a ligand for CRIg to recognize Gram-positive bacteria.
To further determine the specificity of CRIg binding to LTA of S. aureus, we tested LTA synthase enzyme-deficient (DltaS) S. aureus strains. These strains are LTA deficient but have compensatory mutations to keep them viable (Corrigan et al., 2011) . In striking contrast to WT S. aureus, CRIg was incapable of binding any of the LTA-deficient mutants ( Figures 3J and 3K) , strongly supporting a role of LTA in CRIg-mediated recognition of Gram-positive bacteria.
CRIg-LTA Recognition Supports Hepatic Capture of Gram-Positive Bacteria
To test if the interaction between LTA and CRIg was functional for liver-mediated sequestration of circulating bacteria, we first investigated whether LTA deficiency led to the dissemination of circulating S. aureus. Indeed, there was less LTA-deficient S. aureus (DltaS-LAC) bacterial burden in the liver, but greatly increased bacterial load in the blood and kidney of infected mice, when compared to WT S. aureus-infected mice ( Figure 4A ). It is worth noting that LTA deficiency leads to numerous changes in the bacteria and may also increase S. aureus opsonization detected by other immunological receptors such that there is still some sequestration of these mutant bacteria. Nevertheless, in the absence of LTA there were fewer bacteria caught in the liver leading to an order of magnitude more bacteria in kidney and blood.
In addition, we tested if LTA injection in vivo could block the CRIg binding to Gram-positive bacteria, resulting in decreased catching of S. aureus by Kupffer cells. Indeed, mice saturated with LTA partially recapitulated the phenotype of CRIg À/À mice, showing decreased numbers of trapped bacteria within Kupffer cells ( Figure 4B ) and increased numbers of circulating bacteria freely streaming along liver sinusoids ( Figure 4C ; Movie 
S3
). Moreover, we found that CRIg À/À mice showed dramatically decreased ability to catch other Gram-positive bacterial strains we tested, including S. aureus (MW2), B. cereus, L. monocytogenes, Enterococcus faecium (E. faecium), Enterococcus hirae (E. hirae), and Bacillus subtilis (B. subtilis) ( Figures 4D and S2 ; Movie S4). WT mice saturated with LTA from E. hirae and B. subtilis could also partially block their catching of E. hirae and B. subtilis ( Figure S2 ). In addition, we found most of these Grampositive bacteria, except B. cereus, are caught normally by Kupffer cells in C3 À/À mice ( Figure S3 ). Taken together, these data strongly support a contribution of CRIg-LTA recognition in Kupffer-cell-mediated capture of circulating Gram-positive bacteria.
DISCUSSION
The fundamental role of liver in capturing circulating bacteria was examined in this study using imaging technologies, which revealed that about 70% of total bacterial inoculums were quickly sequestrated by Kupffer cells within the first 5 min following i.v. infection. The liver-mediated bacterial capture plays a critical role in limiting the dissemination of bacteria into other susceptible organs during blood-borne infections, such as catheter-related bloodstream infections, which has rapidly become one of the most common nosocomial infections within intensive care units (Gahlot et al., 2014) . Selective trapping of circulating bacteria by the liver rather than other organs may represent an evolutionary strategy to rapidly clear invading bacteria, not only because the liver contains the largest tissue resident macrophage pool, but also because the liver has an incredible capacity to regenerate after various insults. In addition, the immune tolerance properties of the liver may help to restrict inflammation following hepatic bacterial sequestration (Crispe, 2003) . It is also noteworthy that although neutrophils were recruited to the liver, this only occurred after the capture of the pathogen by Kupffer cells. In fact, neutrophils lack CRIg Bacterial load from the liver, blood, and kidney were counted as CFUs. Data were shown as mean ± SEM and were from two independent experiments; each dot represents one mouse (n = 6). (B and C) WT mice were infected with S. aureus (USA-300-GFP) and simultaneously i.v. injected with or without (Ctrl) 1 mg purified LTA. Time-lapse liver intravital imaging was performed; the numbers of (B) caught bacteria or (C) free-floating bacteria per FOV were counted every minute. n = 3 to 4 for each group. The representative of two independent experiments was shown. (D) WT mice were i.v. infected with S. aureus MW2-GFP (top, green), Syto60 labeled B. cerus (2 nd row, red, pseudocolor), L. monocytogenes (3 rd row, red, pseudocolor), or E. faecium (bottom, red, pseudocolor) , representative intravital liver images at 10 min post-infection were shown. Scale bars: 100 mm. At the right side of the panel, the numbers of intrahepatic captured bacteria were counted 10 min post-infection and normalized to the numbers of WT mice for each bacterial strain (capture efficiency = number of captured bacteria in CRIg À/À mice/average number of captured bacteria in WT mice). Data are shown as mean ± SEM and are the representative of at least two independent experiments. n = 4 to 5 per group. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figures S2 and S3 and Movies S3 and S4. expression and the direct capacity to catch bacteria from the mainstream of blood. Instead, neutrophils have been reported to use neutrophil extracellular traps (NETs) to catch bacteria in blood (McDonald et al., 2012) , and this still happens in CRIg À/À mice (data not shown).
Time-lapse intravital imaging revealed that CRIg was important for the capture of circulating S. aureus, confirming a previous report that measured CFUs to estimate the number of captured bacteria . Paradoxically, we found that the previously identified CRIg ligand, C3, is dispensable for catching circulating S. aureus, suggesting that CRIg may support bacterial capture from bloodstream independent of C3b/iC3b recognition. Given the fact that Kupffer cells catch Gram-positive bacteria in less than one minute after they enter the bloodstream, it is very possible that the extent of complement opsonization in such a short time period is not sufficient to support CRIg-C3b-mediated capture of bacteria under shear conditions. In support of this, Gram-positive bacteria are notoriously difficult to opsonize: they have evolved elaborate immune evasion strategies to divert the effectiveness of complement activation on their surfaces. For example, S. aureus makes staphylococcal complement inhibitor, extracellular fibrinogen-binding protein, and extracellular complement-binding protein, all of which inhibit the deposition of C3b onto their surfaces (Jongerius et al., 2007; Rooijakkers et al., 2005) . It should not be surprising that the host has evolved a way to counter this evasion mechanism. Our findings suggest that one such host-defense mechanism involved direct binding of LTA by CRIg. Given that LTA is an essential molecule for bacterial growth and cell division, loss of this molecule as a strategy for evading immunity is not likely and as such makes a good target for efficient capture of many Gram-positive bacteria.
In this work, we have identified LTA as a ligand for CRIg, suggesting that CRIg is a functional pattern recognition receptor that can recognize bacterial components directly. Interestingly, Kupffer cells expressed several other receptors that recognize LTA, including scavenger receptor (SR)-A1 and CD36 (reviewed in Canton et al., 2013) . Whether they participate in assisting CRIg-mediated bacterial catching remains unknown. Previous work has reported that bacteria use catch bonds between receptor-ligand interactions to adhere under shear conditions. A characteristic of such receptors is the increasing affinity as shear forces increase (Sokurenko et al., 2008) . This may therefore be the distinguishing feature of CRIg relative to other LTA receptors. It is also worth noting that LTA-recognizing receptors usually can act as signaling molecules leading to the initiation of inflammation. Whether CRIg is able to transduce similar cellular signaling to initiate inflammation is worthy of further investigation.
In conclusion, our study reveals that bacterial capture under shear conditions in vivo is a highly coordinated biological process, which does not absolutely require target opsonization but does require pattern recognition. We were able to directly visualize and characterize the mechanisms underlying the bacterial capture in vivo. Our finding that Kupffer cells efficiently capture circulating Gram-positive bacteria via CRIg-mediated recognition of LTA represents the discovery of a pattern recognition function.
EXPERIMENTAL PROCEDURES
Mice C57BL/6, C3 À/À , C4 À/À , C5 À/À , Rag1 À/À , and Mac-1 À/À mice were obtained from The Jackson laboratory; FcgR À/À mice were obtained from Taconic Farms; CRIg À/À mice were from Dr. Menno Van Lookeren Campagne (Genetech Inc.). All mouse colonies were maintained in specific-pathogen-free facilities at the University of Calgary. The animal experiments were approved by the University of Calgary Animal Care Committee (Protocol#AC12-0162) and were performed in accordance with the guidelines established by the Canadian Council for Animal Care.
Bacteria
All Gram-positive bacteria were grown BHI media, and Gram-negative bacteria were grown in LB media. The cultures were grown overnight, followed by subculture until logarithmic phase (OD 660 nm = 1). When necessary, the following antibiotics were used: 10 mg/ml chloramphenicol for the pCM29 plasmid. Detailed information about bacterial strains can be found in the Supplemental Experimental Procedures Intravital Microscopy of the Bacterial Capture within Liver Spinning-disk confocal intravital microscopy of mouse liver was performed as previously described (Lee et al., 2010; Wong et al., 2013) . For in vivo imaging of bacterial capture, time-lapse images were captured from À1 min to 20-30 min post-infection at a speed of two images per minute. A total of six to seven fields of view were recorded for each mouse under a 103 microscope objective. Images or movies were exported as .tiff or .avi, respectively, and processed and analyzed with a Volocity analysis software (v. 6.3 Improvision). The minimum threshold values were adjusted for each of the fluorescence channels to reduce background. The same threshold values were applied to images/movies from all treatment groups. The numbers of captured bacteria per field of view (FOV) were calculated by using the ''Find object'' function of Volocity software. Bacteria trapped within Kupffer cells for more than five time points (2.5 min) were considered as captured.
Flow Cytometry of CRIg Binding to Bacteria
Recombinant mouse or human extracellular domain of CRIg with a His-Tag (Creative Biomart) were labeled with AF 647 using a protein labeling kit according to the manufacturer's instructions. AF 647-labeled recombinant CRIg protein (20 mg/ml or indicated concentrations) was incubated with 2 3 10 5 CFU subcultured bacteria at room temperature for 2 to 3 hr with shaking. Bacterial cells were then washed three times, resuspended in fixation buffer (1% PFA), and subjected to flow cytometry. For competitive binding assays, recombinant CRIg was incubated with bacteria in the presence of purified peptidoglycan or LTA (from S. aureus, Sigma-Aldrich) at indicated concentration.
Statistical Analysis
Data were expressed as mean ± SEM and analyzed by an overall one-way ANOVA with Tukey's test for multiple groups' comparisons, or by unpaired student's t test for comparison between two groups.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, four movies, and Supplemental Experimental Procedures and can be found with this article online at http://dx.doi.org/10.1016/j.chom.2016.06.002.
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